CytomX

+$0.27 (+4.96%) Today
-$0.02 (-0.35%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CytomX and other ETFs, options, and stocks.

About CTMX

CytomX Therapeutics, Inc. engages in the development of antibody therapeutics for the treatment of cancer based on its Probody therapeutic technology platform. Its pipeline includes immunotherapies, probody drug conjugates, T cell engaging bispecifics, and other multiple programs.

CEO
Sean A. McCarthy
Employees
146
Headquarters
South San Francisco, California
Founded
2010

CTMX Key Statistics

Market Cap
474.56M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
708.50K
High Today
$5.73
Low Today
$5.43
Open Price
$5.43
Volume
593.20K
52 Week High
$10.05
52 Week Low
$5.31

CTMX Earnings

-$0.79
-$0.44
-$0.09
$0.26
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 9, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure